📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An 111 In-labelled bis-ruthenium( ii ) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells (2020)

First Author: Gill M

Attributed to: University of Oxford Confidence in Concept Scheme – Round 4 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d0sc02825h

PubMed Identifier: 33815738

Publication URI: http://europepmc.org/abstract/MED/33815738

Type: Journal Article/Review

Parent Publication: Chemical Science

Issue: 33

ISSN: 2041-6520